lenvatinib
eisai pharmaceutical
['lenva', 'lcsm,(-blcsm)', 'eisai']
encouraging data in area lacking evidence, managed to secure lenvatinib on compassionate access from as 2nd line for a patient with advanced thymic squamous cell, going to see him in clinic today, can discuss the results with him #lcsm #asco22 
Medical Oncologist